Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin detemir using continuous glucose monitoring: a randomized, cross-over, pilot study.

Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin detemir using continuous glucose monitoring: a randomized, cross-over, pilot study.

Item

http://www.wikidata.org/entity/Q51272007

Q51272007

about

Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study.Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes.

P2860

Q33879458-52DFB36A-76C1-40E6-B936-258BA4D65F54 Q54961900-B8103FAA-9856-46D4-82C5-A4B42B14CE3C

P2860

Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin detemir using continuous glucose monitoring: a randomized, cross-over, pilot study.

Item

http://www.wikidata.org/entity/Q51272007

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Comparison of glycemic variabi ...... ized, cross-over, pilot study.

@en

Comparison of glycemic variabi ...... ized, cross-over, pilot study.

@nl

type

Item

label

Comparison of glycemic variabi ...... ized, cross-over, pilot study.

@en

Comparison of glycemic variabi ...... ized, cross-over, pilot study.

@nl

prefLabel

Comparison of glycemic variabi ...... ized, cross-over, pilot study.

@en

Comparison of glycemic variabi ...... ized, cross-over, pilot study.

@nl

P1476

Comparison of glycemic variabi ...... ized, cross-over, pilot study.

@en

P2093

Daisuke Tsujino

http://www.w3.org/2001/XMLSchema#string

Hiroshi Takahashi

http://www.w3.org/2001/XMLSchema#string

Kazunori Utsunomiya

http://www.w3.org/2001/XMLSchema#string

Kiyotaka Ando

http://www.w3.org/2001/XMLSchema#string

Rimei Nishimura

http://www.w3.org/2001/XMLSchema#string

Yoshiko Onda

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Insulin degludec in Japanese patients with type 1 diabetes mellitus: A randomized controlled trial.

Association between impaired cardiovascular autonomic function and hypoglycemia in patients with type 1 diabetes.

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority tria

Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial.

Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical

Insulin degludec/insulin aspart administered once daily at any meal, with insulin aspart at other meals versus a standard basal-bolus regimen in patients with type 1 diabetes: a 26-week, phase 3, randomized, open-label, treat-to-target trial.

Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long)

Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension

P304

335-342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2017.1293652

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28234565

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

Insulin

glucose monitoring

Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin detemir using continuous glucose monitoring: a randomized, cross-over, pilot study.

about

P2860

P2860

Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin detemir using continuous glucose monitoring: a randomized, cross-over, pilot study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921